Aztreonam Combination Therapy: An Answer to Metallo-β-Lactamase-Producing Gram-Negative Bacteria?

Clin Infect Dis. 2020 Aug 14;71(4):1099-1101. doi: 10.1093/cid/ciz1159.

Authors

Ryan K Shields^{1

2}, Yohei Doi^{1

2

3}

Affiliations

¹ Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
² Center for Innovative Antimicrobial Therapy, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
³ Departments of Microbiology and Infectious Diseases, Fujita Health University, Toyoake, Japan.

No abstract available

Keywords: beta-lactamase inhibitor; carbapenemase; monobactam; pharmacokinetics.

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

Azabicyclo Compounds
Aztreonam*
Bacteremia*
Bacterial Proteins
Ceftazidime
Drug Combinations
Enterobacter
Humans
Klebsiella pneumoniae
beta-Lactamases

Substances

Azabicyclo Compounds
Bacterial Proteins
Drug Combinations
avibactam, ceftazidime drug combination
Ceftazidime
beta-Lactamases
beta-lactamase NDM-1
carbapenemase
Aztreonam

Grants and funding